Testing effectiveness (Phase 2)Study completedNCT02076633What this trial is testingIntratumoral Administration of L19IL2/L19TNFWho this might be right forMalignant Melanoma, Skin Philogen S.p.A. 21
Testing effectiveness (Phase 2)UnknownNCT05097378What this trial is testingPerioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV MelanomaWho this might be right forMelanomaCancer CCTU- Cancer Theme 45
Not applicableUnknownNCT04158544What this trial is testingImmune Monitoring in Metastatic MelanomaWho this might be right forMetastatic Melanoma University of Regensburg 100
Testing effectiveness (Phase 2)Study completedNCT00847106What this trial is testingAugmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma PatientsWho this might be right forMelanoma Radboud University Medical Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348What this trial is testingStudy of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)Who this might be right forNon-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more Replimune, Inc. 340
Large-scale testing (Phase 3)Looking for participantsNCT05727904What this trial is testingStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Who this might be right forMetastatic MelanomaUnresectable MelanomaMelanoma Iovance Biotherapeutics, Inc. 670
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00383292What this trial is testingTasisulam in Treating Participants With Malignant MelanomaWho this might be right forMetastatic Melanoma Eli Lilly and Company 130
Very early researchLooking for participantsNCT07586904What this trial is testingEfficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.Who this might be right forMelanoma (Skin Cancer) Xijing Hospital 10
Large-scale testing (Phase 3)Study completedNCT00019682What this trial is testingAldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaWho this might be right forRecurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more National Cancer Institute (NCI) 185
Testing effectiveness (Phase 2)Study completedNCT02126579What this trial is testingPhase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR AgonistsWho this might be right forMelanomaMetastatic MelanomaMucosal Melanoma Craig L Slingluff, Jr 50
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Testing effectiveness (Phase 2)Ended earlyNCT00082875What this trial is testingCilengitide in Treating Patients With Unresectable or Metastatic MelanomaWho this might be right forStage III MelanomaStage IV Melanoma National Cancer Institute (NCI) 56
Post-approval studies (Phase 4)Ended earlyNCT01683188What this trial is testingHD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic MelanomaWho this might be right forMetastatic Melanoma Clinigen, Inc. 53
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Study completedNCT01069627What this trial is testingAvastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902What this trial is testingNeoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV Diwakar Davar 48
Early research (Phase 1)Study completedNCT00091143What this trial is testingFludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanoma (Skin) Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02414750What this trial is testingVemurafenib Plus Cobimetinib in Metastatic MelanomaWho this might be right forMetastatic Melanoma Netherlands Working Group on Immunotherapy of Oncology 78
Early research (Phase 1)Study completedNCT01066390What this trial is testingA Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV MelanomaWho this might be right forMelanoma Bart Neyns 18